RELMADA THERAPEUTICS, INC. Short-term Debt, Fair Value
RELMADA THERAPEUTICS, INC. (RLMD) had Short-term Debt, Fair Value of $104.06 million as of 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Notes › Debt
us-gaap:ShorttermDebtFairValue · last filed 2023-08-08
- 2023-06-30: Short-term Debt, Fair Value $104.06M.
- 2023-03-31: Short-term Debt, Fair Value $103.55M.
- 2022-12-31: Short-term Debt, Fair Value $142.93M.
- 2022-09-30: Short-term Debt, Fair Value $141.63M.
| Period end | Short-term Debt, Fair Value |
|---|---|
| 2023-06-30 | $104.06M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $103.55M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $142.93M 10-K · filed 2023-03-23 |
| 2022-09-30 | $141.63M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $174.69M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $175.72M 10-Q · filed 2022-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |